This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hartl, P Articles by Lipp, M Search for Related Content PubMed PubMed Citation Articles by Hartl, P Articles by Lipp, M

Next Article 

Mol Cell Biol. 1987 June; 7(6): 2037-2045

Generation of a variant t(2;8) translocation of Burkitt's lymphoma by site-specific recombination via the kappa light-chain joining signals.

ABSTRACT

We analyzed the Burkitt's lymphoma line BL64 in which a reciprocal translocation joins the immunoglobulin kappa light-chain locus on chromosome 2 to the c-myc gene on chromosome 8. The breakpoints on the two marker chromosomes 8+ and 2p- occurred 5' of the Js segment within the conserved nonamer and heptamer recombination sequences. Both signals were detected directly adjacent to the breakpoints in sequences of chromosome 8 suggesting that the translocation in BL64 was catalyzed by enzymes normally involved in V-J recombination. The distance between the c-myc gene and the breakpoint in J kappa amounts to at least 90 kilobases on the DNA level. In one allele of the c-myc gene somatic mutations were found in the promoter-leader region. This allele is transcribed and is supposed to be involved in the translocation. The half-life of the c-myc-specific mRNA in BL64 cells is not prolonged in comparison to the normal c-myc message. These results suggest that in Burkitt's lymphoma the translocation occurs during an early stage of B-cell differentiation and that in the variant translocations mechanisms other than a prolonged half-life, such as changes in transcriptional rates, or other posttranscriptional RNA processing contribute to the high steady-state level of c-myc RNA in the cytoplasm.

This article has been cited by other articles:

• Hopken, U. E., Foss, H.-D., Meyer, D., Hinz, M., Leder, K., Stein, H., Lipp, M. (2002). Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 99: 1109-1116 [Abstract] [Full Text]  
• Retiere, C., Halary, F., Peyrat, M.-A., Le Deist, F., Bonneville, M., Hallet, M.-M. (1999). The Mechanism of Chromosome 7 Inversion in Human Lymphocytes Expressing Chimeric {gamma}{beta} TCR. J. Immunol. 162: 903-910 [Abstract] [Full Text]  
• Guldner, H., Szostecki, C, Schroder, P, Matschl, U, Jensen, K, Luders, C, Will, H, Sternsdorf, T (1999). Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif. J. Cell Sci. 112: 733-747 [Abstract]  
• Wolf, I., Pevzner, V., Kaiser, E., Bernhardt, G., Claudio, E., Siebenlist, U., Forster, R., Lipp, M. (1998). Downstream Activation of a TATA-less Promoter by Oct-2, Bob1, and NF-kappa B Directs Expression of the Homing Receptor BLR1 to Mature B Cells. J. Biol. Chem. 273: 28831-28836 [Abstract] [Full Text]  
• Goossens, T., Klein, U., Kuppers, R. (1998). Frequent occurrence of deletions and duplications during somatic hypermutation: Implications for oncogene translocations and heavy chain disease. Proc. Natl. Acad. Sci. USA 95: 2463-2468 [Abstract] [Full Text]  
• Grotzinger, T., Jensen, K., Will, H. (1996). The Interferon (IFN)-stimulated Gene Sp100 Promoter Contains an IFN-gamma Activation Site and an Imperfect IFN-stimulated Response Element Which Mediate Type I IFN Inducibility. J. Biol. Chem. 271: 25253-25260 [Abstract] [Full Text]  
• Thalmeier, K, Synovzik, H, Mertz, R, Winnacker, E L, Lipp, M (1989). Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.. Genes Dev. 3: 527-536 [Abstract]